Cargando…
microRNA-329 reduces bone cancer pain through the LPAR1-dependent LPAR1/ERK signal transduction pathway in mice
BACKGROUND: Bone cancer pain (BCP) is a common symptom occurring among patients with cancer and has a detrimental effect on their quality of life. Growing evidence has implicated microRNA-329 (miR-329) in the progression of bone diseases. In the present study, we aimed to elucidate the potential eff...
Autores principales: | Wu, Xian-Ping, Yang, Yan-Ping, She, Rui-Xuan, Xing, Zu-Min, Chen, Han-Wen, Zhang, Yi-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811758/ https://www.ncbi.nlm.nih.gov/pubmed/31692673 http://dx.doi.org/10.1177/1758835919875319 |
Ejemplares similares
-
The Roles of Lpar1 in Central Nervous System Disorders and Diseases
por: Xiao, Dongqiong, et al.
Publicado: (2021) -
Inhibition of LPA-LPAR1 and VEGF-VEGFR2 Signaling in IPF Treatment
por: Luo, Ya-Li, et al.
Publicado: (2023) -
LPAR5 confers radioresistance to cancer cells associated with EMT activation via the ERK/Snail pathway
por: Sun, Xiao-Ya, et al.
Publicado: (2022) -
Conditional Lpar1 gene targeting identifies cell types mediating neuropathic pain
por: Rivera, Richard R., et al.
Publicado: (2020) -
Designing Dual Inhibitors of Autotaxin-LPAR GPCR Axis
por: Banerjee, Souvik, et al.
Publicado: (2022)